clenbuterol has been researched along with Left Ventricular Hypertrophy in 2 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol treatment induced 26% left ventricular hypertrophy." | 3.70 | Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. ( Bishop, J; Boheler, KR; Petrou, M; Wong, K; Yacoub, MH, 1998) |
| "The examination of the heart showed left ventricular hypertrophy, while the right coronary artery showed only a small vascular lumen (3 mm in diameter), due to its anatomical structure." | 1.51 | Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone). ( Andresen-Streichert, H; Geyer, H; Glenewinkel, F; Juebner, M; Lehmann, S; Rothschild, MA; Schiwy-Bochat, KH; Thevis, M; Thomas, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lehmann, S | 1 |
| Thomas, A | 1 |
| Schiwy-Bochat, KH | 1 |
| Geyer, H | 1 |
| Thevis, M | 1 |
| Glenewinkel, F | 1 |
| Rothschild, MA | 1 |
| Andresen-Streichert, H | 1 |
| Juebner, M | 1 |
| Wong, K | 1 |
| Boheler, KR | 1 |
| Bishop, J | 1 |
| Petrou, M | 1 |
| Yacoub, MH | 1 |
2 other studies available for clenbuterol and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone).
Topics: Adult; Anabolic Agents; Androstanols; Clenbuterol; Clomiphene; Coronary Vessels; Doping in Sports; F | 2019 |
Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features.
Topics: Adenosine Triphosphatases; Adrenergic beta-Agonists; Animals; Calcium-Binding Proteins; Calcium-Tran | 1998 |